Immunotherapy and Breast Cancer – Recent Trials Raise Questions The results from the Impassion130 and Impassion131 trials of atezolizumab in […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
Immunotherapy and Breast Cancer – Recent Trials Raise Questions The results from the Impassion130 and Impassion131 trials of atezolizumab in […]
We all want immunotherapy to “work” for breast cancer patients. For the National Breast Cancer Coalition, that means therapy that […]
It’s now easier than ever to take action through our Advocacy Action Center. Each year, we develop legislative and public […]
Check Out Our New Website As you’ve probably read in our previous emails, NBCC officially launched its new mobile-friendly website, […]
NBCC Remembers Congressman John Lewis – A Message From Fran Visco Not long after we launched our Deadline2020 Campaign, several […]
John Lewis was an extraordinary man. His passing leaves all of us at the National Breast Cancer Coalition (NBCC) with […]
